The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines.
We evaluated the effect of the human immunodeficiency virus (HIV) protease inhibitor saquinavir on the imatinib-sensitive and imatinib-resistant chronic myelogenous leukemia cell lines. Saquinavir, which is also a proteasome blocker, showed dose- and time-related anti-proliferative activity, particularly on the imatinib-resistant lines and a pro-apoptotic effect. Association with imatinib caused a significant increase of activity.
Timeus
Fabio
F
Crescenzio
Nicoletta
N
Ricotti
Emanuela
E
Doria
Alessandra
A
Bertin
Daniele
D
Saglio
Giuseppe
G
Tovo
Pier Angelo
PA